The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
12h
GlobalData on MSNFDA tags Medtronic embolisation device recall as Class IMedtronic initiated the recall of certain Pipeline Vantage embolisation devices in January 2025 following reports of four ...
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
Medtronic (MDT) stock turned lower as the FDA announced a most serious type of recall involving its Pipeline Vantage 027 ...
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
The FDA announced that Medtronic initiated a device recall and correction for embolization devices. The FDA has identified ...
The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage ...
7d
MedPage Today on MSNFDA's Deadline Ignored in Nearly 30% of Device Safety ReportsNearly 10% of postmarket device safety reports in MAUDE were submitted over 6 months after the safety event occurred.
Asia's ability to supply sustainable aviation fuel will outpace regional demand this year and next as more production comes ...
Four of the 132 patients treated with Varipulse in the first two months of the U.S. launch had a form of stroke shortly after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results